|Articles|November 1, 2012
- Applied Clinical Trials-11-01-2012
- Volume 21
- Issue 11
Act Cover
S
Advertisement
Cover
Articles in this issue
over 13 years ago
Taking the Pulse of Ethics Committee Viewsover 13 years ago
Survey Results of Start-Up Cycle Timesover 13 years ago
Business and News Update November 2012over 13 years ago
Act Insert coverover 13 years ago
Pediatric Drug Developmentover 13 years ago
ePRO Industry Growthover 13 years ago
Generic Drugs Making Wavesover 13 years ago
In the Race to Capture Clinical Data, Does Data Quality Suffer?over 13 years ago
Are CRCs Reaching Their Tipping Point?over 13 years ago
EMA's Mid-Year Report Merits ScrutinyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5